Black and Hispanic patients have increased mortality rates and lower rates of coronary interventions following in-hospital cardiac arrest.

REVB READ THE FULL REVB RESEARCH REPORT Revelation Biosciences (NASDAQ:REVB) announced that it has initiated its US based Phase 1b clinical study to evaluate the potential of Gemini as a ...

The global cardiovascular devices market, valued at US$72.83 billion in 2023, is forecasted to grow at a robust CAGR of 7.3%, ...

As Finance Minister Nirmala Sitharaman prepares to announce the Union Budget 2025 on February 1, experts have shared their ...